Literature DB >> 22054598

Re-evaluation of the phenotypic changes in L4 dorsal root ganglion neurons after L5 spinal nerve ligation.

Tetsuo Fukuoka1, Hiroki Yamanaka, Kimiko Kobayashi, Masamichi Okubo, Kan Miyoshi, Yi Dai, Koichi Noguchi.   

Abstract

The L5 spinal nerve ligation (SNL) is a widely used animal neuropathic pain model. There are conflicting reports regarding the extent of injury to the L4 dorsal root ganglion (DRG) neurons in this model. If a significant number of these neurons were injured, the previously reported phenotypic and electrophysiological changes at this level are in need of re-evaluation by separating the injured neurons and the frankly spared ones. So, we immunostained activating transcription factor 3 (ATF3) and examined the change in expression of transcripts for neuropeptide Y (NPY), brain-derived neurotrophic factor (BDNF) and several voltage-gated sodium channel α-subunits (Nav1.1, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9) in the L4 DRG by comparing signal intensities of individual neurons using in situ hybridization histochemistry. ATF3-immunoreactivity was similarly observed in 4-6% of neuronal nuclei of the SNL and sham-operated ipsilateral L4 DRGs. Comparison between ATF3+ and ATF3- neurons in the SNL L4 DRG revealed that (1) whereas NPY induction occurred in ATF3+ cells, BDNF increased mainly in ATF3- neurons; (2) although ATF3+ neurons had higher Nav1.3 signals than ATF3- neurons, these signals were much lower than those of the L5 DRG neurons; and (3) ATF3+/N52- neurons selectively lost Nav1.8 and Nav1.9 mRNAs. Comparison of the total neuronal populations among naïve, SNL, and sham-operated rats revealed no significant differences for all examined Nav mRNAs. Because neuropathic pain behaviors were developed by rats with SNL but not the sham-operation, the small number of injured L4 neurons likely do not contribute to the pathomechanisms of neuropathic pain.
Copyright © 2011 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054598     DOI: 10.1016/j.pain.2011.09.009

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  14 in total

1.  Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1.

Authors:  Yi-Chen Lee; Shui-Chin Lu; Yu-Lin Hsieh
Journal:  J Vis Exp       Date:  2018-02-13       Impact factor: 1.355

2.  Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states.

Authors:  Doo-Sik Kim; Kang-Wu Li; Amin Boroujerdi; Yanhui Peter Yu; Chun-Yi Zhou; Ping Deng; John Park; Xia Zhang; Joshua Lee; Michael Corpe; Kelli Sharp; Oswald Steward; Cagla Eroglu; Ben Barres; Frank Zaucke; Zao C Xu; Z David Luo
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

3.  Dorsal root ganglion stimulation of injured sensory neurons in rats rapidly eliminates their spontaneous activity and relieves spontaneous pain.

Authors:  Dongman Chao; Christina M Mecca; Guoliang Yu; Ian Segel; Michael S Gold; Quinn H Hogan; Bin Pan
Journal:  Pain       Date:  2021-12-01       Impact factor: 6.961

Review 4.  Tetrodotoxin (TTX) as a therapeutic agent for pain.

Authors:  Francisco Rafael Nieto; Enrique José Cobos; Miguel Ángel Tejada; Cristina Sánchez-Fernández; Rafael González-Cano; Cruz Miguel Cendán
Journal:  Mar Drugs       Date:  2012-01-31       Impact factor: 6.085

5.  Tissue injury and related mediators of pain exacerbation.

Authors:  Fumimasa Amaya; Yuta Izumi; Megumi Matsuda; Mika Sasaki
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

6.  Voltage-gated sodium channel expression in mouse DRG after SNI leads to re-evaluation of projections of injured fibers.

Authors:  Cédric J Laedermann; Marie Pertin; Marc R Suter; Isabelle Decosterd
Journal:  Mol Pain       Date:  2014-03-11       Impact factor: 3.395

7.  A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Authors:  Song Cai; Peter Tuohy; Chunlong Ma; Naoya Kitamura; Kimberly Gomez; Yuan Zhou; Dongzhi Ran; Shreya Sai Bellampalli; Jie Yu; Shizhen Luo; Angie Dorame; Nancy Yen Ngan Pham; Gabriella Molnar; John M Streicher; Marcel Patek; Samantha Perez-Miller; Aubin Moutal; Jun Wang; Rajesh Khanna
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

8.  Gene therapy for neuropathic pain by silencing of TNF-α expression with lentiviral vectors targeting the dorsal root ganglion in mice.

Authors:  Nobuhiro Ogawa; Hiromichi Kawai; Tomoya Terashima; Hideto Kojima; Kazuhiro Oka; Lawrence Chan; Hiroshi Maegawa
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

9.  EXPRESS: Voltage-dependent sodium (NaV) channels in group IV sensory afferents.

Authors:  Renuka Ramachandra; Keith S Elmslie
Journal:  Mol Pain       Date:  2016-07-05       Impact factor: 3.395

10.  Effects of peripheral nerve injury on parvalbumin expression in adult rat dorsal root ganglion neurons.

Authors:  Tom Medici; Peter J Shortland
Journal:  BMC Neurosci       Date:  2015-12-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.